Nivestym (filgrastim)

pCPA File Number: 21205

Negotiation Status:

Concluded with an LOI

Indication(s):

Neutropenia in various indications (Prevention or treatment)

Sponsor/Manufacturer:

Pfizer Canada ULC

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2020-04-27

Negotiation Process Concluded:

2020-06-17